A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...
Hosted on MSN2d
Fewer girls in Stockport protected against HPVFewer girls in Stockport received the HPV vaccine in the last school year, new figures show. It comes as health experts have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback